Recent Finacing
Recent Raise
Prokaryotics discovers and develops novel antibiotics using bacterial physiology and screening to target outer membrane biogenesis and natural-product cell wall synthesis inhibitors for multidrug-resistant Neisseria gonorrhoeae.
